Literature DB >> 26316566

A New Aneurysm Occlusion Classification after the Impact of Flow Modification.

H S Cekirge1, I Saatci2.   

Abstract

A new classification is proposed for cerebral aneurysms treated with any endovascular technique, for example, coiling with or without adjunctive devices, flow diversion, intrasaccular flow modifiers, or any combination of the above. Raymond-Roy Occlusion Classification is expanded with novel subgroups such as class 1 represents complete occlusion and is subdivided if a branch is integrated to, or originated from, the aneurysm sac; class 2 represents neck filling; class 3 represents incomplete occlusion with aneurysm filling as in the previous classification; and class 4 describes the immediate postoperative status after extra- or intrasaccular flow modification treatment. A new concept, "stable remodeling," is included as class 5, which represents filling in the neck region that stays unchanged or reduced, as shown with at least 2 consecutive control angiographies, at least 6 months apart, for not <1 year, or the remodeled appearance of a dilated and/or tortuous vessel in continuation with the parent artery without sac filling.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26316566      PMCID: PMC7960201          DOI: 10.3174/ajnr.A4489

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  24 in total

1.  A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents.

Authors:  C J O'kelly; T Krings; D Fiorella; T R Marotta
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

2.  WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study.

Authors:  B Lubicz; J Klisch; J-Y Gauvrit; I Szikora; M Leonardi; T Liebig; N P Nuzzi; E Boccardi; F D Paola; M Holtmannspötter; W Weber; E Calgliari; V Sychra; B Mine; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-23       Impact factor: 3.825

3.  Angiographic outcome of intracranial aneurysms with neck remnant following coil embolization.

Authors:  Justin R Mascitelli; Eric K Oermann; Reade A De Leacy; Henry Moyle; Aman B Patel
Journal:  J Neurointerv Surg       Date:  2014-05-02       Impact factor: 5.836

4.  Endovascular treatment of unruptured aneurysms.

Authors:  D Roy; G Milot; J Raymond
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms.

Authors:  D Fiorella; P Lylyk; I Szikora; M E Kelly; F C Albuquerque; C G McDougall; P K Nelson
Journal:  J Neurointerv Surg       Date:  2009-06-16       Impact factor: 5.836

6.  Intrasaccular flow-disruption treatment of intracranial aneurysms: preliminary results of a multicenter clinical study.

Authors:  L Pierot; T Liebig; V Sychra; K Kadziolka; F Dorn; C Strasilla; C Kabbasch; J Klisch
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-07       Impact factor: 3.825

7.  Characterizing patterns of endothelialization following coil embolization: a whole-mount, dual immunostaining approach.

Authors:  Daying Dai; Yong-Hong Ding; Issa Rezek; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2015-02-02       Impact factor: 5.836

8.  Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils.

Authors:  Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

9.  Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study.

Authors:  S Claiborne Johnston; Christopher F Dowd; Randall T Higashida; Michael T Lawton; Gary R Duckwiler; Daryl R Gress
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  Simple measurement of aneurysm residual after treatment: the SMART scale for evaluation of intracranial aneurysms treated with flow diverters.

Authors:  Iris Quasar Grunwald; M Kamran; R A Corkill; A L Kühn; I S Choi; S Turnbull; D Dobson; K Fassbender; D Watson; M J Gounis
Journal:  Acta Neurochir (Wien)       Date:  2011-10-16       Impact factor: 2.216

View more
  5 in total

1.  Middle Cerebral Artery Bifurcation Aneurysms Treated by Extrasaccular Flow Diverters: Midterm Angiographic Evolution and Clinical Outcome.

Authors:  C Iosif; C Mounayer; K Yavuz; S Saleme; S Geyik; H S Cekirge; I Saatci
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-15       Impact factor: 3.825

2.  Long-term clinical and angiographic follow-up results of the dual-layer flow diverter device (FRED) for the treatment of intracranial aneurysms in a multicenter study.

Authors:  Hasan Dinc; Isil Saatci; Sukru Oguz; Feyyaz Baltacioglu; Altan Yildiz; Halil Donmez; Umit Belet; Baran Onal; Cagatay Andic; Osman Koc; Omer Kocak; Mert Koroglu; Mustafa Cetin; H Saruhan Cekirge
Journal:  Neuroradiology       Date:  2021-01-03       Impact factor: 2.804

3.  p64 flow diverter: Results in 108 patients from a single center.

Authors:  Tom De Beule; T Boulanger; S Heye; W J van Rooij; W H van Zwam; L Stockx
Journal:  Interv Neuroradiol       Date:  2020-06-06       Impact factor: 1.610

4.  Low-profile Visualized Intraluminal Support Junior Device for the Treatment of Intracranial Aneurysms.

Authors:  Mihir Gupta; Vincent J Cheung; Peter Abraham; Arvin R Wali; David R Santiago-Dieppa; Brandon C Gabel; Abdulrahman Almansouri; J Scott Pannell; Alexander A Khalessi
Journal:  Cureus       Date:  2017-02-17

5.  A novel score for evaluating cerebral aneurysms treated with flow diversion: 4F-flow diversion predictive score.

Authors:  Huibin Kang; Bin Luo; Jian Liu; Anxin Wang; Hongqi Zhang; Tianxiao Li; Donglei Song; Yuanli Zhao; Sheng Guan; Yunyan Wang; Wenfeng Feng; Yang Wang; Huaizhang Shi; Jianmin Liu; Xinjian Yang
Journal:  Ther Adv Neurol Disord       Date:  2021-08-19       Impact factor: 6.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.